Bio-Rad Laboratories Inc Stock News

Investors are optimistic about STERIS (STE) on impressive growth across its operating segments.

Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.

Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.

Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.

Investors are optimistic about Exact Sciences (EXAS) on strong buoyed by Cologuard volume growth.

Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.

Edwards Lifesciences' (EW) stock rallies on impressive fourth-quarter performance and bullish 2022 guidance.

Bio-Rad Laboratories provides a range of products for the life science and clinical diagnostics markets.

Investors are optimistic about Align Technology (ALGN) on the growing market adoption of the iTero Element 5D Plus imaging system.

Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.

Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.

Investors are optimistic about Thermo Fisher (TMO) on its progress with COVID-19-related products and services.

According to QIAGEN (QGEN), QuantiFERON is different from other IGRA tests based on its efficient workflow.

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Despite the near-term COVID-19 challenges, Syneos Health (SYNH) remains confident about the long-term strength of its business given the robust backlog and the unique market position.